UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047034
Receipt number R000053661
Scientific Title The changes from first visit in dietary intake by means of food frequency questionnaire in treatment-naive patients with type 2 diabetes
Date of disclosure of the study information 2022/02/28
Last modified on 2022/02/28 16:32:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The changes from first visit in dietary intake by means of food frequency questionnaire in treatment-naive patients with type 2 diabetes

Acronym

The changes from first visit in dietary intake by means of food frequency questionnaire in treatment-naive patients with type 2 diabetes

Scientific Title

The changes from first visit in dietary intake by means of food frequency questionnaire in treatment-naive patients with type 2 diabetes

Scientific Title:Acronym

The changes from first visit in dietary intake by means of food frequency questionnaire in treatment-naive patients with type 2 diabetes

Region

Japan


Condition

Condition

Type 2 Diabetes Mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To retrospectively assess the changes from first visit in dietary intake by means of food frequency questionnaire in treatment-naive patients with type 2 diabetes

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Changes from first visit in total energy intake and intake of three macronutrients (carbohydrate, protein, and fat)

Key secondary outcomes

1.Changes in HbA1c, body mass index and antidiabetic drugs
2.Changes in the ratio of three macronutrients
3.Changes in the ratio of main nutrients
4.Changes in serum uric acid and triglyceride, and the relationship between their parameters and total energy intake or intake of three macronutrients


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Treatment-naive patients with type 2 diabetes
2.Aged >=20 years (irrespective of sex)
3.Patients who have assessment of 1-week food frequency questionnaire at least 3 times from first visit

Key exclusion criteria

1.Patients in the study is judged by the investigator or sub-investigator as inappropriate for any other reason

Target sample size

13


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Osonoi

Organization

Naka Kinen Clinic

Division name

department of internal medicine

Zip code

311-0113

Address

745-5 Nakadai, Naka-shi, Ibaraki

TEL

029-353-2800

Email

t-osonoi@kensei-kai.com


Public contact

Name of contact person

1st name Kensuke
Middle name
Last name Ofuchi

Organization

Naka Kinen Clinic

Division name

Department of clinical research laboratory

Zip code

311-0113

Address

745-5 Nakadai, Naka-shi, Ibaraki

TEL

029-353-2800

Homepage URL


Email

k-ofuchi@kensei-kai.com


Sponsor or person

Institute

Naka Kinen Clinic

Institute

Department

Personal name



Funding Source

Organization

Hakubaku Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the ethics review committee of the Naka Kinen Clinic

Address

745-5 Nakadai, Naka-shi, Ibaraki

Tel

029-353-2800

Email

t-osonoi@kensei-kai.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

那珂記念クリニック(茨城県)


Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

13

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 10 Month 18 Day

Date of IRB

2021 Year 10 Month 27 Day

Anticipated trial start date

2021 Year 10 Month 27 Day

Last follow-up date

2022 Year 01 Month 31 Day

Date of closure to data entry

2022 Year 02 Month 04 Day

Date trial data considered complete

2022 Year 02 Month 10 Day

Date analysis concluded

2022 Year 03 Month 18 Day


Other

Other related information

Dietary intake in Japanese outpatients with type 2 diabetes: 2-year follow up study.


Management information

Registered date

2022 Year 02 Month 28 Day

Last modified on

2022 Year 02 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053661